Small Pharma Top Insiders
DMTTFDelisted Stock | USD 0.05 0.0009 1.80% |
Small Pharma employs about 10 people. The company is managed by 10 executives with a total tenure of roughly 24 years, averaging almost 2.0 years of service per executive, having 1.0 employees per reported executive. Examination of Small Pharma's management performance can provide insight into the company performance.
Sarah Hamilton Insider Group Controller |
LLB HBA Insider Co Sec |
Small |
Small Pharma Management Team Effectiveness
The company has return on total asset (ROA) of (0.4124) % which means that it has lost $0.4124 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.7826) %, meaning that it generated substantial loss on money invested by shareholders. Small Pharma's management efficiency ratios could be used to measure how well Small Pharma manages its routine affairs as well as how well it operates its assets and liabilities.Small Pharma Workforce Comparison
Small Pharma is one of the top stocks in number of employees category among its peers. The total workforce of Biotechnology industry is currently estimated at about 396. Small Pharma holds roughly 10.0 in number of employees claiming about 2.53% of stocks in Biotechnology industry.
Small Pharma Notable Stakeholders
A Small Pharma stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Small Pharma often face trade-offs trying to please all of them. Small Pharma's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Small Pharma's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Sarah Hamilton | Group Controller | Profile | |
LLB HBA | Co Sec | Profile | |
George Tziras | CEO Director | Profile | |
David Steel | Chief Officer | Profile | |
Peter Rands | Founder Officer | Profile | |
Carol Routledge | Chief Officer | Profile | |
MD MSc | Chief Officer | Profile | |
Jenny Maguire | Head Communications | Profile | |
Emma Hodge | Head Property | Profile | |
Marie Layzell | Chief Director | Profile |
About Small Pharma Management Performance
The success or failure of an entity such as Small Pharma often depends on how effective the management is. Small Pharma management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Small management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Small management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Small Pharma Inc., a biotechnology company, focuses on developing short-acting psychedelics with therapy for the treatment of mental health conditions. The company was incorporated in 2015 and is headquartered in London, the United Kingdom. Small Pharma is traded on OTC Exchange in the United States.
The data published in Small Pharma's official financial statements typically reflect Small Pharma's business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Small Pharma's quantitative information. For example, before you start analyzing numbers published by Small accountants, it's essential to understand Small Pharma's liquidity, profitability, and earnings quality within the context of the Healthcare space in which it operates.
Small Pharma Workforce Analysis
Traditionally, organizations such as Small Pharma use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Small Pharma within its industry.Small Pharma Manpower Efficiency
Return on Small Pharma Manpower
Revenue Per Employee | 0.0 | |
Revenue Per Executive | 0.0 | |
Net Loss Per Employee | 2.2M | |
Net Loss Per Executive | 2.2M |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Consideration for investing in Small OTC Stock
If you are still planning to invest in Small Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Small Pharma's history and understand the potential risks before investing.
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
CEOs Directory Screen CEOs from public companies around the world | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |